As of Dec 15
| 0.00 / 0.00%|
The 6 analysts offering 12-month price forecasts for Lexicon Pharmaceuticals Inc have a median target of 24.00, with a high estimate of 38.00 and a low estimate of 9.70. The median estimate represents a +135.53% increase from the last price of 10.19.
The current consensus among 7 polled investment analysts is to Buy stock in Lexicon Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.